Literature DB >> 30505473

A physiological approach to refine appropriateness of revascularization, clinical decision making and prognosis in patients with multi vessel coronary artery disease.

Linle Hou1, Bobby Ghosh1, Abdul Hakeem1.   

Abstract

Entities:  

Year:  2018        PMID： 30505473      PMCID： PMC6236180          DOI： 10.21037/jtd.2018.09.134

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  24 in total

Review 1.  The SYNTAX score: usefulness, limitations, and future directions.

Authors:  Anjan K Chakrabarti; C Michael Gibson
Journal:  J Invasive Cardiol       Date:  2011-12       Impact factor: 2.022

2.  Quantification of incomplete revascularization and its association with five-year mortality in the synergy between percutaneous coronary intervention with taxus and cardiac surgery (SYNTAX) trial validation of the residual SYNTAX score.

Authors:  Vasim Farooq; Patrick W Serruys; Christos V Bourantas; Yaojun Zhang; Takashi Muramatsu; Ted Feldman; David R Holmes; Michael Mack; Marie Claude Morice; Elisabeth Ståhle; Antonio Colombo; Ton de Vries; Marie-angèle Morel; Keith D Dawkins; Arie-Pieter Kappetein; Friedrich W Mohr
Journal:  Circulation       Date:  2013-06-13       Impact factor: 29.690

3.  Angiographic predictors of graft patency and disease progression after coronary artery bypass grafting with arterial and venous grafts.

Authors:  H I Manninen; P Jaakkola; M Suhonen; S Rehnberg; R Vuorenniemi; P J Matsi
Journal:  Ann Thorac Surg       Date:  1998-10       Impact factor: 4.330

4.  Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With Left Main and Multivessel Coronary Artery Disease: Do We Have the Evidence?

Authors:  Bernard J Gersh; Gregg W Stone; Deepak L Bhatt
Journal:  Circulation       Date:  2017-02-28       Impact factor: 29.690

5.  Six-Year Follow-Up of Fractional Flow Reserve-Guided Versus Angiography-Guided Coronary Artery Bypass Graft Surgery.

Authors:  Stephane Fournier; Gabor G Toth; Bernard De Bruyne; Nils P Johnson; Giovanni Ciccarelli; Panagiotis Xaplanteris; Anastasios Milkas; Teresa Strisciuglio; Jozef Bartunek; Marc Vanderheyden; Eric Wyffels; Filip Casselman; Frank Van Praet; Bernard Stockman; Ivan Degrieck; Emanuele Barbato
Journal:  Circ Cardiovasc Interv       Date:  2018-06       Impact factor: 6.546

6.  Angiographic versus functional severity of coronary artery stenoses in the FAME study fractional flow reserve versus angiography in multivessel evaluation.

Authors:  Pim A L Tonino; William F Fearon; Bernard De Bruyne; Keith G Oldroyd; Massoud A Leesar; Peter N Ver Lee; Philip A Maccarthy; Marcel Van't Veer; Nico H J Pijls
Journal:  J Am Coll Cardiol       Date:  2010-06-22       Impact factor: 24.094

7.  Functional SYNTAX score for risk assessment in multivessel coronary artery disease.

Authors:  Chang-Wook Nam; Fabio Mangiacapra; Robert Entjes; In-Sung Chung; Jan-Willem Sels; Pim A L Tonino; Bernard De Bruyne; Nico H J Pijls; William F Fearon
Journal:  J Am Coll Cardiol       Date:  2011-09-13       Impact factor: 24.094

8.  SYNTAX Score and Long-Term Outcomes: The BARI-2D Trial.

Authors:  Fumiaki Ikeno; Maria Mori Brooks; Kaori Nakagawa; Min-Kyu Kim; Hideaki Kaneda; Yoshiaki Mitsutake; Helen A Vlachos; Leonard Schwartz; Robert L Frye; Sheryl F Kelsey; Katsuhisa Waseda; Mark A Hlatky
Journal:  J Am Coll Cardiol       Date:  2017-01-31       Impact factor: 24.094

9.  Fractional flow reserve-guided coronary artery bypass grafting: can intraoperative physiologic imaging guide decision making?

Authors:  T Bruce Ferguson; Cheng Chen; Joseph D Babb; Jimmy T Efird; Ramesh Daggubati; John M Cahill
Journal:  J Thorac Cardiovasc Surg       Date:  2013-08-01       Impact factor: 5.209

10.  Does stenosis severity of native vessels influence bypass graft patency? A prospective fractional flow reserve-guided study.

Authors:  Cornelis J Botman; Jacques Schonberger; Sjaak Koolen; Olaf Penn; Hilde Botman; Nabil Dib; Eric Eeckhout; Nico Pijls
Journal:  Ann Thorac Surg       Date:  2007-06       Impact factor: 4.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.